Copanlisib population pharmacokinetics from phase I–III studies and exposure–response relationships in combination with rituximab.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 11, p. 1666, doi. 10.1002/psp4.13000

By:

• Morcos, Peter N.;
• Moss, Jonathan;
• Austin, Rupert;
• Hiemeyer, Florian;
• Zinzani, Pier Luigi;
• Beckert, Vita;
• Mongay Soler, Lidia;
• Childs, Barrett H.;
• Garmann, Dirk

Publication type:

Article